Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis
- PMID: 38001503
- PMCID: PMC10675877
- DOI: 10.1186/s12936-023-04794-x
Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis
Abstract
Background: Chemoprophylaxis is a prevention method for malaria during travel in malaria-endemic countries. This study aimed to collate and synthesize the evidence of malarial chemoprophylaxis among malaria death cases.
Methods: Studies documenting malarial chemoprophylaxis related to malaria deaths were searched in PubMed, Scopus, MEDLINE, Embase, and CENTRAL until 3 July 2022. The pooled proportion of malarial chemoprophylaxis among death cases was synthesized using logit transformation and back transformation to a proportion performed using generalized linear mixed models. The pooled log odds ratio (log-OR) with a 95% confidence interval (CI) of malarial chemoprophylaxis in death cases compared to survivors were synthesized.
Results: Fifty-eight studies were included in the systematic review and the meta-analysis. Of 602 pooled malaria death cases, the number of patients who took chemoprophylaxis was 187 (30%) (95% CI 22-40, P < 0.01, 58 studies), and those who took adequate chemoprophylaxis were 24 (5%) (95% CI 2-13, P < 0.01, 42 studies). A comparable log-OR of underwent chemoprophylaxis was observed between malaria death cases and survivors (P = 0.94, pooled log-OR: - 0.02, 95% CI - 0.46-0.42, I2: 0%, 17 studies). Similarly, a comparable log-OR of adequate chemoprophylaxis was identified between malaria death cases and survivors (P = 0.15, pooled log-OR: 0.83, 95% CI - 0.30-1.97, I2: 47.08%, 11 studies).
Conclusions: Among the studies where malarial chemoprophylaxis was reported, approximately 30% of malaria death cases had taken such prophylaxis. Notably, only 5% of these cases adhered fully or adequately to the recommended chemoprophylactic regimen. However, the analysis did not reveal a significant difference in the odds of malarial chemoprophylaxis between malaria death cases and survivors.
Keywords: Chemoprophylaxis; Compliance; Deaths; Malaria; Travelers.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Prevalence, anti-malarial chemoprophylaxis and causes of deaths for severe imported malaria: A systematic review and meta-analysis.Travel Med Infect Dis. 2022 Sep-Oct;49:102408. doi: 10.1016/j.tmaid.2022.102408. Epub 2022 Aug 17. Travel Med Infect Dis. 2022. PMID: 35985533
-
Malaria Surveillance - United States, 2016.MMWR Surveill Summ. 2019 May 17;68(5):1-35. doi: 10.15585/mmwr.ss6805a1. MMWR Surveill Summ. 2019. PMID: 31099769
-
Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis.J Travel Med. 2021 Jul 7;28(5):taab057. doi: 10.1093/jtm/taab057. J Travel Med. 2021. PMID: 33834208
-
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):726-32. doi: 10.1016/j.tmaid.2014.08.005. Travel Med Infect Dis. 2014. PMID: 25443997
-
Self-diagnosis and self-treatment of Plasmodium spp. infection by travellers (1989-2019): A systematic review and meta-analysis.Travel Med Infect Dis. 2020 Nov-Dec;38:101902. doi: 10.1016/j.tmaid.2020.101902. Epub 2020 Oct 23. Travel Med Infect Dis. 2020. PMID: 33132136
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical